Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-25-002184
Filing Date
2025-04-01
Accepted
2025-04-01 17:05:10
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2024 sunshine_i10k-123124.htm   iXBRL 10-K 972274
2 INSIDER TRADING POLICY sunshine_ex1900.htm EX-19 34346
3 CONSENT OF BUSH & ASSOCIATES CPA LLC sunshine_ex2301.htm EX-23.1 5203
4 CERTIFICATION sunshine_ex3101.htm EX-31.1 8365
5 CERTIFICATION sunshine_ex3102.htm EX-31.2 8358
6 CERTIFICATION sunshine_ex3201.htm EX-32.1 3760
12 GRAPHIC image_001.jpg GRAPHIC 6215
13 GRAPHIC image_002.jpg GRAPHIC 7280
  Complete submission text file 0001683168-25-002184.txt   5673343

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20241231.xsd EX-101.SCH 48153
8 XBRL CALCULATION FILE sbfm-20241231_cal.xml EX-101.CAL 63601
9 XBRL DEFINITION FILE sbfm-20241231_def.xml EX-101.DEF 176014
10 XBRL LABEL FILE sbfm-20241231_lab.xml EX-101.LAB 385197
11 XBRL PRESENTATION FILE sbfm-20241231_pre.xml EX-101.PRE 337127
94 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123124_htm.xml XML 624250
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 25800708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)